Urokinase-type plasminogen activator receptor (uPAR) as a therapeutic target in cancer

Abstract Urokinase-type plasminogen activator receptor (uPAR) is an attractive target for the treatment of cancer, because it is expressed at low levels in healthy tissues but at high levels in malignant tumours. uPAR is closely related to the invasion and metastasis of malignant tumours, plays impo...

Full description

Saved in:
Bibliographic Details
Main Authors: Bingtao Zhai, Huan Tian, Jing Sun, Junbo Zou, Xiaofei Zhang, Jiangxue Cheng, Yajun Shi, Yu Fan, Dongyan Guo
Format: Revisão
Language:English
Published: 2022
Online Access:https://doi.org/10.1186/s12967-022-03329-3
https://translational-medicine.biomedcentral.com/track/pdf/10.1186/s12967-022-03329-3
Tags: Add Tag
No Tags, Be the first to tag this record!